Cell Banking Outsourcing Market Size, Growth, Trends, Forecast 2027

Summary

Report Description

The global cell banking outsourcing market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include the increase in chronic diseases, rising awareness among parental population, and rise in geriatric population, which are propelling the growth of the market. The cell banking outsourcing is an ability that stores cells of a particular genome for the future purpose. The cell banking outsourcing can be used to produce complete characterizations of cell lines and can also help to reduce the cross-contamination of a cell line. The other factors supporting the market's growth are extensive investments in research and development (R&D) activities, expanding number of clinical trials, rising demand for stem cell therapies and gene therapies, rise in research activities related to stem cell applications, increasing demand for biologic products, development of advanced preservation techniques, large number of clinical trials, and expansion of healthcare industry are bolstering the growth of the market. Also, the growing adoption of collaboration and acquisition strategies by the market players are supporting the growth of the market.

Rising Prevalence of chronic Diseases and Increasing Geriatric Population

The increasing occurrence of chronic diseases such as diabetes, cardiovascular diseases, and others, across the globe are strengthening the growth of the market. According to the WHO, Cardiovascular diseases (CVDs) are the leading cause of death worldwide, taking an approximated 17.9 million lives each year. Stem cells are used to treat various chronic diseases as these diseases cannot be treated with traditional methods due to their adverse effect. Therefore, use of stem cell therapy for the treatment act as a healing agent which helps to reduce the risk or damage caused by the treatment. Owing to the continuous rise in the number of people suffering from these fatal diseases, the demand for stem cell therapies and gene therapies are rising, which is driving the growth of the market.

Increasing Geriatric Population Supports the Market

Rise in geriatric populations base across the world is surging the demand for stem cell therapy, which is impelling the growth of the market. According to the World Health Organization (WHO) data, the number and proportion of elderly population, meaning the people with the age of 60 years and above in the population is increasing. In 2019, the number of people with the age of 60 years and above was 1 billion. This number is likely to rise to 1.4 billion by 2030 and 2.1 billion by 2050.

Growing Awareness About Stem Cell Banking

Growing awareness about stem cell banking across the various emerging countries are augmenting the growth of the market. Nowadays, people are becoming more aware of the benefits regarding stem cell banking for future purposes. Parental as well as expectant populations are becoming more aware as health specialists are starting to educate them about the significance and advantages of storing stem cells which is fueling the growth of the market, globally. For instance, in the United States, the donor registry contains above 9 million potential donors. In addition, the donor registry includes 266,000 cord blood units from which 115,000 units are from National Cord Blood Inventory (NCBI), with over 4000 NCBI units added in 2021.

Download Free Sample Report

Market Segmentation

The global cell banking outsourcing market is segmented into type, cell type, phase, and company. Based on type, the market is divided into master cell banking, working cell banking, and viral cell banking. Based on cell type, the market is divided into stem cell and non-stem cell. Based on phase, the market is divided into bank storage, bank characterization & testing, and bank preparation. In terms of country, the United States is expected to be a lucrative market in the forecast period due to growing prevalence of chronic and genetic disorders in the country.

Market Players

Cryo-Cell International, Inc, Charles River Laboratories International, Inc., Goodwin Biotechnology Inc., Lonza Group AG, SGS Life Sciences (SGS SA), Global Stem Inc., BSL Bioservice Scientific Laboratories GmbH, and BioReliance Corporation are some of the leading companies operating in the market.

Attribute	Details
Base Year	2021
Historic Data	2017 – 2020
Estimated Year	2022
Forecast Period	2023 – 2027
Quantitative Units	Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	· Type · Cell Type · Phase · Company
Regional scope	North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa
Country scope	United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa; Australia; Turkey; Egpyt
Key companies profiled	Cryo-Cell International, Inc, Charles River Laboratories International, Inc., Goodwin Biotechnology Inc., Lonza Group AG, SGS Life Sciences (SGS SA), Global Stem Inc., BSL Bioservice Scientific Laboratories GmbH, and BioReliance Corporation
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global cell banking outsourcing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

· Cell Banking Outsourcing Market, By Type:

o Master Cell Banking

o Working Cell Banking

o Viral Cell Banking

· Cell Banking Outsourcing Market, By Cell Type:

o Stem Cell

o Non-Stem Cell

· Cord Blood Banking, By Phase:

o Bank Storage

o Bank Characterization & Testing

o Bank Preparation

· Cell Banking Outsourcing Market, By Region:

North America

United States
Canada
Mexico

Asia-Pacific

China
India
Japan
Australia
South Korea

Europe & CIS

Germany
France
United Kingdom
Spain
Italy

South America

Brazil
Argentina
Colombia

Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Turkey

§ Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Cell Banking Outsourcing Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Cell Banking Outsourcing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Cell Banking Outsourcing Market

5. Voice of Customer

6. Global Cell Banking Outsourcing Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking)

6.2.2. By Cell Type (Stem Cell v/s Non-Stem Cell)

6.2.3. By Phase (Bank Storage, Bank Characterization & Testing, Bank Preparation)

6.2.4. By Company (2021)

6.2.5. By Region

6.3. Market Map

7. North America Cell Banking Outsourcing Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Type

7.2.2. By Cell Type

7.2.3. By Phase

7.2.4. By Country

7.3. North America: Country Analysis

7.3.1. United States Cell Banking Outsourcing Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Type

7.3.1.2.2. By Cell Type

7.3.1.2.3. By Phase

7.3.2. Canada Cell Banking Outsourcing Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Type

7.3.2.2.2. By Cell Type

7.3.2.2.3. By Phase

7.3.3. Mexico Cell Banking Outsourcing Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Type

7.3.3.2.2. By Cell Type

7.3.3.2.3. By Phase

8. Europe Cell Banking Outsourcing Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Type

8.2.2. By Cell Type

8.2.3. By Phase

8.2.4. By Country

8.3. Europe: Country Analysis

8.3.1. France Cell Banking Outsourcing Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Type

8.3.1.2.2. By Cell Type

8.3.1.2.3. By Phase

8.3.2. Germany Cell Banking Outsourcing Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Type

8.3.2.2.2. By Cell Type

8.3.2.2.3. By Phase

8.3.3. United Kingdom Cell Banking Outsourcing Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Type

8.3.3.2.2. By Cell Type

8.3.3.2.3. By Phase

8.3.4. Italy Cell Banking Outsourcing Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Type

8.3.4.2.2. By Cell Type

8.3.4.2.3. By Phase

8.3.5. Spain Cell Banking Outsourcing Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Type

8.3.5.2.2. By Cell Type

8.3.5.2.3. By Phase

9. Asia-Pacific Cell Banking Outsourcing Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Type

9.2.2. By Cell Type

9.2.3. By Phase

9.2.4. By Country

9.3. Asia-Pacific: Country Analysis

9.3.1. China Cell Banking Outsourcing Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Type

9.3.1.2.2. By Cell Type

9.3.1.2.3. By Phase

9.3.2. India Cell Banking Outsourcing Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Type

9.3.2.2.2. By Cell Type

9.3.2.2.3. By Phase

9.3.3. Japan Cell Banking Outsourcing Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Type

9.3.3.2.2. By Cell Type

9.3.3.2.3. By Phase

9.3.4. South Korea Cell Banking Outsourcing Market Outlook

9.3.4.1. Market Size & Forecast

9.3.4.1.1. By Value

9.3.4.2. Market Share & Forecast

9.3.4.2.1. By Type

9.3.4.2.2. By Cell Type

9.3.4.2.3. By Phase

9.3.5. Australia Cell Banking Outsourcing Market Outlook

9.3.5.1. Market Size & Forecast

9.3.5.1.1. By Value

9.3.5.2. Market Share & Forecast

9.3.5.2.1. By Type

9.3.5.2.2. By Cell Type

9.3.5.2.3. By Phase

10. South America Cell Banking Outsourcing Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Type

10.2.2. By Cell Type

10.2.3. By Phase

10.2.4. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Cell Banking Outsourcing Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Type

10.3.1.2.2. By Cell Type

10.3.1.2.3. By Phase

10.3.2. Argentina Cell Banking Outsourcing Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Type

10.3.2.2.2. By Cell Type

10.3.2.2.3. By Phase

10.3.3. Colombia Cell Banking Outsourcing Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Type

10.3.3.2.2. By Cell Type

10.3.3.2.3. By Phase

11. Middle East and Africa Cell Banking Outsourcing Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Type

11.2.2. By Cell Type

11.2.3. By Phase

11.2.4. By Country

11.3. MEA: Country Analysis

11.3.1. South Africa Cell Banking Outsourcing Market Outlook

11.3.1.1. Market Size & Forecast

11.3.1.1.1. By Value

11.3.1.2. Market Share & Forecast

11.3.1.2.1. By Type

11.3.1.2.2. By Cell Type

11.3.1.2.3. By Phase

11.3.2. Saudi Arabia Cell Banking Outsourcing Market Outlook

11.3.2.1. Market Size & Forecast

11.3.2.1.1. By Value

11.3.2.2. Market Share & Forecast

11.3.2.2.1. By Type

11.3.2.2.2. By Cell Type

11.3.2.2.3. By Phase

11.3.3. UAE Cell Banking Outsourcing Market Outlook

11.3.3.1. Market Size & Forecast

11.3.3.1.1. By Value

11.3.3.2. Market Share & Forecast

11.3.3.2.1. By Type

11.3.3.2.2. By Cell Type

11.3.3.2.3. By Phase

11.3.4. Turkey Cell Banking Outsourcing Market Outlook

11.3.4.1. Market Size & Forecast

11.3.4.1.1. By Value

11.3.4.2. Market Share & Forecast

11.3.4.2.1. By Type

11.3.4.2.2. By Cell Type

11.3.4.2.3. By Phase

11.3.5. Egypt Cell Banking Outsourcing Market Outlook

11.3.5.1. Market Size & Forecast

11.3.5.1.1. By Value

11.3.5.2. Market Share & Forecast

11.3.5.2.1. By Type

11.3.5.2.2. By Cell Type

11.3.5.2.3. By Phase

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Cryo-Cell International, Inc

14.2. Charles River Laboratories International, Inc.

14.3. Goodwin Biotechnology Inc.

14.4. Lonza Group AG

14.5. SGS Life Sciences (SGS SA)

14.6. Global Stem Inc.

14.7. BSL Bioservice Scientific Laboratories GmbH

14.8. BioReliance Corporation

15. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Cell Banking Outsourcing Market?

An increase in fatal chronic disorders, growing awareness among people, and awareness among parental population are driving the demand for the global cell banking outsourcing market.

Who are the top players operating in the Global Cell Banking Outsourcing Market?

Cryo-Cell International, Inc, Charles River Laboratories International, Inc., Goodwin Biotechnology Inc., Lonza Group AG, SGS Life Sciences (SGS SA), Global Stem Inc., BSL Bioservice Scientific Laboratories GmbH, and BioReliance Corporation are the key players operating in the global cell banking outsourcing market.

What are the key factors hampering growth for the Global Cell Banking Outsourcing Market?

Major factors causing hindrance for the growth of the market includes high operating cost of stem cell therapeutics, availability of right donors, stringent regulatory standards, risk associated with cell line banking, and ethical concerns.